Page last updated: 2024-09-04

jtt 501 and Hyperglycemia

jtt 501 has been researched along with Hyperglycemia in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jain, VS; Ramaa, CS; Vora, DK1
Matsui, K; Shibata, T; Wakitani, K; Yonemori, F1

Reviews

1 review(s) available for jtt 501 and Hyperglycemia

ArticleYear
Thiazolidine-2,4-diones: progress towards multifarious applications.
    Bioorganic & medicinal chemistry, 2013, Apr-01, Volume: 21, Issue:7

    Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents; Antineoplastic Agents; Arthritis, Rheumatoid; Bacterial Infections; Drug Design; Enzyme Inhibitors; Humans; Hyperglycemia; Hypoglycemic Agents; Mycoses; Neoplasms; PPAR gamma; Structure-Activity Relationship; Thiazolidinediones

2013

Other Studies

1 other study(ies) available for jtt 501 and Hyperglycemia

ArticleYear
JTT-501, a novel oral antidiabetic agent, improves insulin resistance in genetic and non-genetic insulin-resistant models.
    British journal of pharmacology, 1998, Volume: 125, Issue:8

    Topics: Animals; Blood Glucose; Disease Models, Animal; Glucose; Glucose Clamp Technique; Glucose Tolerance Test; Hyperglycemia; Hypoglycemic Agents; Infusions, Intravenous; Insulin; Insulin Resistance; Isoxazoles; Leptin; Lipids; Male; Obesity; Oxidation-Reduction; Phosphorylation; Proteins; Rats; Rats, Sprague-Dawley; Rats, Zucker; Receptor, Insulin; Triglycerides

1998